PATENT CLAIM ANALYSIS

Application Number: 16097782
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "335000"]

Abstract:
Provided herein are methods for treating a subject in need of such treatment comprising administering a therapeutically effective amount of one or more pharmaceutical compositions comprising a 1,2-HOPO chelating agent and/or a 3,2-HOPO chelating agent to a subject in need of such treatment. The subject can be one who has been, or will be, exposed to one or more known or unknown actinides and/or lanthanides, or a mixture thereof.

Claim (Index 1):
A method for treating a subject for a heavy metal exposure, the method comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a 1,2-HOPO chelating agent to a subject that has an excess amount of one or more of gadolinium, lead, tin, yttrium, scandium, or cadmium, wherein administering results in decorporating, clearing or reducing the amount of gadolinium, lead, tin, or cadmium from the subject.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.64444
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10194502', '15119678', '10875182', '11743740', '12373275']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7259248984966862
- 35 USC 102 Novelty (BERT): 0.501675485189
- Combined Prediction Score: 0.7034999571659176
- Mean Citation Score: 165.57821
- Max Citation Score: 187.36992
- Similarity Product: 110.80873305913929

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test